Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Cambria Plans Parkinson's, ALS Research With Three NIH Grants

Feb. 17, 2005

By Jennifer Boggs

Inverness Acquiring Ischemia In Stock Deal Worth $22.4M

Feb. 17, 2005

By Jennifer Boggs

Inverness Acquiring Ischemia In Stock Deal Worth $22.4M

Feb. 17, 2005

By Jennifer Boggs

Cambria Plans Parkinson's, ALS Research With Three NIH Grants

Feb. 17, 2005

By Jennifer Boggs

Vertex, Avalon Sign $73M Cancer Drug Agreement

Feb. 16, 2005

By Jennifer Boggs

Vertex, Avalon Sign $73M Cancer Drug Agreement

Feb. 16, 2005

By Jennifer Boggs

Accentia Files For $86M IPO To Fund Trials, Pay Off Debt

Feb. 15, 2005

By Jennifer Boggs

ConjuChem Raises C$21.7M For Upcoming DAC Studies

Feb. 15, 2005

By Jennifer Boggs

ConjuChem Raises C$21.7M For Upcoming DAC Studies

Feb. 15, 2005

By Jennifer Boggs

Accentia Files For $86M IPO To Fund Trials, Pay Off Debt

Feb. 15, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...